Will the zero-margin drug policy reduce the economic burden of stroke patients in China?

BACKGROUND: China is facing a more severe stroke challenge. In 2017, China fully implemented the zero-margin drug policy (ZMDP), cancelling 15% of drug markups in public hospitals. Based on the “System of Health Accounts 2011” (SHA 2011), this paper explores the changes in the economic burden of str...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Quan, Shang, Degao, Zhang, Yunxia, Geng, Xinli, Liu, Fang, Zhang, Qin, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2021
Materias:
Research Theme 4: Health Transitions in China
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501452/
https://www.ncbi.nlm.nih.gov/pubmed/34671464
http://dx.doi.org/10.7189/jogh.11.08007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501452/
https://www.ncbi.nlm.nih.gov/pubmed/34671464
http://dx.doi.org/10.7189/jogh.11.08007

Ejemplares similares